December 7,2016
GlaxoSmithKline (GSK)[1] and Johnson & Johnson (J&J) are first and second overall in the Access to Medicine Index (ATMI), which ranks the degree to which pharmaceutical companies have made their medicines accessible to people in low and middle-income countries. The biennial ranking was announced on November 14 by the Access to Medicine Foundation, which published its first such ranking in 2008. “The ranking provides the big picture – which company is best, overall, at mobilizing to re...
December 1,2016
Experts issue a call to strengthen the global strategy against soil-transmitted helminthiasis and schistosomiasis. Eighteen NTD experts, including CWW Scientific Advisor David Addiss, call for revisions of the global strategy for treating STH and schistosomiasis in a recent publication. They recommend changing the current strategy of treating children to treating communities to reduce morbidity and reinfection. The authors stress the need for guidance tailored to meet specific programmatic goals...